Ignite Creation Date:
2024-05-06 @ 10:31 AM
Last Modification Date:
2024-10-26 @ 12:31 PM
Study NCT ID:
NCT03284294
Status:
UNKNOWN
Last Update Posted:
2020-04-02
First Post:
2017-09-04
Brief Title:
Influence of Vitamin D Supplementation on Serum BDNF Level and Cognitive Function in Schizophrenia
Sponsor:
Universitas Padjadjaran
Organization:
Universitas Padjadjaran
Study Overview
Official Title:
The Influence of Vitamin D Supplementation on Serum Brain Derived Neurotrophic Factor Level and Cognitive Function in Schizophrenia Treated With Atypical Antipsychotic
Status:
UNKNOWN
Status Verified Date:
2020-03
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of the study is to evaluate the influence of vitamin D supplementation on Serum Brain Derived Neurotrophic Factor level and cognitive function in schizophrenia treated with atypical antipsychotic Methods The investigator will use randomized controlled trial design 40 chronic schizophrenia patients with vitamin D insufficiency or deficiency treated with atypical antipsychotic will be randomly assign 11 ratio to receive either daily oral cholecalciferol 2000 IU or placebo for 8 weeks Assessment of BDNF serum and cognitive function will be performed at baseline and after 8 weeks period
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None